
Individualizing HIV Care to Optimize Patient Outcomes
Advances in the treatment of human immunodeficiency virus (HIV) have allowed patients to achieve a better quality of life. With careful management, the life expectancy of patients can approximate that of uninfected people. Despite this, progress in controlling the HIV epidemic has been modest, and targets for improvement in key indicators set by the National HIV/AIDS Strategy (NHAS) have not been met. HIV specialists and health care decision makers within the managed care setting must be familiar with the diverse treatements and antiretroviral therapies in order to individualize treatment to the specific needs and preferences of each patient, to assure long-term adherence and continued viral suppression.
This activity will provide an opportunity to address the identified gaps in knowledge and practice and encourage population health decision-makers to change their practice behaviors to improve their patients’ health.
Educational Partner: Vindico Medical Education
In Collaboration with: Specialty Healthcare Benefits Council
Medium: Online Presentation
Commerical Support: This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.
Target Audience
The intended audience for this activity is medical directors, pharmacy directors, and other population health decision-makers from US health plans and healthcare delivery systems.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Investigate the impact of antiretroviral therapy selection on factors that influence therapeutic effectiveness in patients with HIV, such as adherence, drug resistance and safety;
- Examine treatment regimens that individualize treatment and meet the clinical and social needs of the patient;
- Evaluate the suitability of different classes of antiretroviral drugs for long-term HIV treatment;
- Assess the factors influencing the below-target outcomes of national programs such as the National HIV/AIDS Strategy (NHAS);
- Assess HIV preventative measures, as well as diagnostic and care initiatives provided through the Affordable Care Act and how they can be effectively incorporated into managed care programs;
- Describe populations at high-risk for HIV and strategies to engage and retain them in the care continuum.
Available credit:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Activity opens:
12/30/2016
Activity expires:
12/30/2017

Chief Executive Officer
Visante Inc. & Visante Ltd.
St. Paul, MN

SVP and Chief Clinical Officer
Envolve PeopleCare
Austin, TX

Associate Clinical Professor of Medicine
George Washington University School of Medicine
Co-Director, DC Dept of Health STD Research Program
Washington, DC
PEER REVIEWER
Chicago, IL
Accreditation Statement
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
To view this activity, you will need to visit the Power-Pak C.E. website at:
ACTIVITY INFORMATION AND REGISTRATION
Please login or create an account to proceed.